Lukas Biomedical Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lukas Biomedical Inc

Watchlist Manager

Watchlist

Price: 18.4 TWD Market Closed

Market Cap: NT$770.4m

L	Lukas Biomedical Inc TPEX:6814	TW
C	CNOOC Ltd DUS:NC2B	CN
F	Feytech Holdings Bhd KLSE:FEYTECH	MY
	Liberty Latin America Ltd F:1LL	US
S	STORE Capital Corp F:S76	US
G	Global Crossing Airlines Group Inc NEO:JET	US
	Element79 Gold Corp F:7YS	CA

Profitability Summary

Lukas Biomedical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

60%

Strong 3Y Average Gross Margin

59%

Gross Margin is Increasing

56% > 60%

Negative Operating Margin

-51%

Negative 3Y Average Operating Margin

-41%

Declining Operating Margin

-17% > -51%

Negative Net Margin

-54%

Negative 3Y Average Net Margin

-43%

Declining Net Margin

-18% > -54%

Negative Free Cash Flow Margin

-40%

Negative 3Y Average Free Cash Flow Margin

-33%

Declining Free Cash Flow Margin

-3% > -40%

Negative ROE

-39%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-19%

Declining ROIC

-8% > -21%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.